Download CLONIDINE PREMEDICATION AND ANESTHETIC EFFECTS

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of beta-blockers wikipedia , lookup

5-HT2C receptor agonist wikipedia , lookup

Nicotinic agonist wikipedia , lookup

Toxicodynamics wikipedia , lookup

Non-specific effect of vaccines wikipedia , lookup

Discovery and development of angiotensin receptor blockers wikipedia , lookup

NK1 receptor antagonist wikipedia , lookup

Stimulant wikipedia , lookup

Cannabinoid receptor antagonist wikipedia , lookup

Bilastine wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Norepinephrine wikipedia , lookup

History of general anesthesia wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
For the Boards…
(2004-2005)
Author: Andrew Spellman, MD
Editor: Dean F. Connors, MD, PhD
CLONIDINE PREMEDICATION AND ANESTHETIC EFFECTS
Andrew Spellman, MD
Definition: Clonidine is primarily an α2 agonist used primarily for its antihypertensive effects (α2
to α1 receptor ratio of 200:1). Alpha-2 receptors are adrenoreceptors that are located primarily
on presynaptic nerve terminals. Activation of these receptors inhibits adenylate cyclase activity,
which in turn decreases the entry of calcium into the neuronal terminal, which limits
norepinephrine release. This leads to an overall decrease in sympathetic outflow, causing
peripheral vasodilatation, as well as negative chronotropic effects, therefore causing a reduction
in blood pressure. This decrease in central sympathetic outflow does not affect baroreceptor
reflexes, therefore not causing orthostatic hypotension. Stimulation of these receptors in the
central nervous system has also been shown to have sedative properties.
Premedication Uses: Clonidine has many desirable effects when used as a premedication for
surgery:
Provides sedation and anxiolysis
Decreases analgesic dosage requirements
Decreases overall anesthetic requirements by decreasing MAC
Provides favorable cardiovascular effects by reducing catecholamine levels, therefore lowering
heart rate and blood pressure during anesthesia (however, has not been shown to reduce
perioperative ischemia)
Decreases postoperative oxygen consumption
When compared with oral midazolam, clonidine was less effective as an anxiolytic but produced a
greater anesthetic and analgesic reducing effect.
Other possible benefits: decreased postoperative shivering, antiemetic effects, decrease in
postoperative delirium, inhibition of opioid induced muscle rigidity. Clonidine is also used
effectively as an adjunct to opioids and local anesthestics to treat acute and chronic pain.
Regional Anesthetic Effects: Clonidine prolongs the duration of peripheral nerve blocks, as
well as decreases dosage requirements for epidural and spinal anesthesia. (Clonidine alone has
been shown to control intraoperative and postoperative pain when administered intrathecally or
epidurally when given in large doses)
Side Effects: Clonidine has been shown to cause dose dependent adverse effects such as
prolonged sedation (especially in the elderly), hypotension, bradycardia, and dry mouth.
Clonidine also mildly potentiates opiate-induced respiratory depression.
The rise in intraocular pressure associated with laryngoscopy and intubation is attenuated.
Abrupt withdrawal from clonidine my cause hypertensive crises (therefore should be continued
throughout the perioperative period). Labetolol can be used to treat the withdrawal syndrome.
Dexmedetomidine: Also an α-2 agonist, is more highly selective for the receptor (α-2 to α-1 ratio
of 1600:1). Provides the same beneficial effects as clonidine, but with a higher potency and
shorter duration of action.
Drug Reversal: Adverse clinical effects of clonidine and dexmedetomidine can be reversed with
atipamezole (a specific antagonist).
Reference:
Morgan, Mikhail, and Murray. Clinical Anesthesiology. Third Edition. McGraw-Hill, Philadelphia,
2002. 218-219
Andrew Spellman, MD
For the Boards…
(2004-2005)
Author: Andrew Spellman, MD
Editor: Dean F. Connors, MD, PhD
Moss, J. and C.L. Renz. The Autonomic Nervous System. Anesthesia. Sixth Edition. Ronald
Miller (Ed), Churchill-Livingston, Philadelphia. 2005. pp. 650-651
Sessler, D. Temperature Monitoring. Anesthesia, Sixth Edition. Ronald Miller (Ed), ChurchillLivingston, Philadelphia. 2005, pp2596-2597.
Andrew Spellman, MD